Tag Archives: Amneal Pharmaceuticals

General Electric (GE:NYS) and Mylan (MYL:NAS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
GE General Electric Co 1 1 6 0 0 0 3.3750 3.2500 Hold
AMRX Amneal Pharmaceuticals Inc 3 0 1 0 0 0 4.5000 4.0000 Outperform
CPA Copa Holdings SA 4 0 0 0 0 0 5.0000 4.5000 Buy
AIT Applied Industrial Technologies Inc 1 0 2 0 0 0 3.6667 3.3333 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
IPL Inter Pipeline Ltd 4 4 5 0 1 0 3.7143 3.6429 Outperform
PBH Premium Brands Holdings Corp 5 3 2 0 0 0 4.3000 4.2000 Outperform
D.UN Dream Office Real Estate Investment Trust 1 1 4 0 0 0 3.5000 3.3333 Hold
ESI Ensign Energy Services Inc 3 1 7 0 0 0 3.6364 3.4545 Outperform
MAL Magellan Aerospace Corp 2 1 0 0 0 0 4.6667 4.0000 Buy
CERV Cervus Equipment Corp 3 1 2 0 0 0 4.1667 3.8333 Outperform
ZCL ZCL Composites Inc 0 2 1 0 0 0 3.6667 3.5000 Outperform
CHW Chesswood Group Ltd 1 1 0 0 0 0 4.5000 4.0000 Outperform
CPH Cipher Pharmaceuticals Inc 3 2 0 0 0 0 4.6000 4.2000 Buy
ENDP Endo International PLC 3 0 4 0 0 0 3.8571 3.5714 Outperform
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
TBP Tetra Bio Pharma Inc 0 1 0 0 0 0 4.0000 0.0000 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
MYL Mylan NV 4 0 3 0 0 0 4.1429 3.8571 Outperform
ENDP Endo International PLC 3 0 4 0 0 0 3.8571 3.5714 Outperform
TWNK Hostess Brands Inc 2 1 2 0 0 0 4.0000 3.8000 Outperform
PZZA Papa John’s International Inc 1 0 0 0 0 0 5.0000 3.0000 Buy
DCPH Deciphera Pharmaceuticals Inc 1 0 0 0 0 0 5.0000 0.0000 Buy
CNST Constellation Pharmaceuticals Inc 1 0 0 0 0 0 5.0000 0.0000 Buy

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

GE:NYS General Electric

http://www.ge.com
General Electric has 313000 employees and is headquartered in United States.
General Electric Co is a digital industrial company. It operates in various segments, including power and water, oil and gas, energy management, aviation, healthcare, transportation, appliances and lighting, and more.

MYL:NAS Mylan

http://www.mylan.com
Mylan has 33417 employees and is headquartered in United Kingdom.
Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.